Latest filing published 23 Dec 2025 for Olema Pharmaceuticals, Inc., €520k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Naseem Zojwalla in Olema Pharmaceuticals, Inc. The record holds 9 filings, for trades running from 20 November 2023 to 19 December 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 23 December 2025, the filings show an option exercise worth €520k in Olema Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations